RMB Capital Management LLC trimmed its position in Walgreens Boots Alliance Inc (NASDAQ:WBA) by 30.5% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 7,584 shares of the pharmacy operator’s stock after selling 3,335 shares during the quarter. RMB Capital Management LLC’s holdings in Walgreens Boots Alliance were worth $518,000 at the end of the most recent reporting period.
Several other hedge funds have also recently modified their holdings of the business. Massey Quick Simon & CO. LLC purchased a new stake in shares of Walgreens Boots Alliance during the 4th quarter worth $27,000. Cornerstone Advisors Inc. lifted its stake in shares of Walgreens Boots Alliance by 102.4% during the 3rd quarter. Cornerstone Advisors Inc. now owns 423 shares of the pharmacy operator’s stock worth $31,000 after purchasing an additional 214 shares during the last quarter. Murphy Pohlad Asset Management LLC purchased a new stake in shares of Walgreens Boots Alliance during the 4th quarter worth $29,000. Brand Asset Management Group Inc. lifted its stake in shares of Walgreens Boots Alliance by 40.7% during the 4th quarter. Brand Asset Management Group Inc. now owns 692 shares of the pharmacy operator’s stock worth $47,000 after purchasing an additional 200 shares during the last quarter. Finally, Laurel Wealth Advisors LLC purchased a new stake in shares of Walgreens Boots Alliance during the 4th quarter worth $52,000. Institutional investors and hedge funds own 61.94% of the company’s stock.
Shares of NASDAQ:WBA opened at $63.77 on Wednesday. Walgreens Boots Alliance Inc has a 1 year low of $59.07 and a 1 year high of $86.31. The stock has a market cap of $59.51 billion, a P/E ratio of 10.59, a price-to-earnings-growth ratio of 1.03 and a beta of 0.88. The company has a current ratio of 0.80, a quick ratio of 0.36 and a debt-to-equity ratio of 0.44.
The company also recently disclosed a quarterly dividend, which was paid on Tuesday, March 12th. Stockholders of record on Friday, February 15th were issued a $0.44 dividend. This represents a $1.76 dividend on an annualized basis and a dividend yield of 2.76%. The ex-dividend date of this dividend was Thursday, February 14th. Walgreens Boots Alliance’s dividend payout ratio is presently 29.24%.
A number of equities research analysts recently weighed in on the company. Zacks Investment Research cut Walgreens Boots Alliance from a “hold” rating to a “sell” rating in a research note on Monday, March 11th. Bank of America restated an “underperform” rating and set a $62.00 price objective (down from $69.00) on shares of Walgreens Boots Alliance in a research note on Friday, March 8th. BidaskClub cut Walgreens Boots Alliance from a “hold” rating to a “sell” rating in a research note on Wednesday, March 6th. Morgan Stanley decreased their price objective on Walgreens Boots Alliance from $77.00 to $67.00 and set an “equal weight” rating for the company in a research note on Tuesday, March 5th. Finally, UBS Group decreased their price objective on Walgreens Boots Alliance from $70.00 to $65.00 and set a “sell” rating for the company in a research note on Monday, March 4th. Six research analysts have rated the stock with a sell rating, ten have assigned a hold rating and five have given a buy rating to the company. Walgreens Boots Alliance presently has a consensus rating of “Hold” and an average target price of $77.94.
WARNING: This news story was originally posted by Ticker Report and is owned by of Ticker Report. If you are accessing this news story on another publication, it was illegally copied and republished in violation of international copyright & trademark law. The legal version of this news story can be read at https://www.tickerreport.com/banking-finance/4235677/rmb-capital-management-llc-lowers-holdings-in-walgreens-boots-alliance-inc-wba.html.
Walgreens Boots Alliance Company Profile
Walgreens Boots Alliance, Inc operates as a pharmacy-led health and wellbeing company. It operates through three segments: Retail Pharmacy USA, Retail Pharmacy International, and Pharmaceutical Wholesale. The Retail Pharmacy USA segment sells prescription drugs and an assortment of retail products, including health, beauty, personal care, consumable, and general merchandise products through its retail drugstores and convenient care clinics.
Featured Story: Why do companies issue stock splits?
Receive News & Ratings for Walgreens Boots Alliance Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance and related companies with MarketBeat.com's FREE daily email newsletter.